Sign in Subscribe
Pediatrics

Sickle Cell Intrahepatic Cholestasis Underlined in New Research

Strategic Insights

— 1 min read

A case study highlights the urgency of early diagnosis and multidisciplinary management of sickle cell intrahepatic cholestasis to avoid liver failure and transplantation. The 24-year-old patient presented with a rare combination of symptoms, including jaundice, encephalopathy, and epistaxis, which led to a diagnosis of SCIC. The patient underwent liver transplantation after experiencing recurrent admissions, symptomatic coagulopathy, and complications. Researchers emphasize the importance of prompt and effective management of SCIC to prevent severe outcomes.

Key Takeaways:

  • Sickle cell intrahepatic cholestasis (SCIC) is a rare but significant complication of sickle cell disease (SCD).
  • SCIC can progress to liver failure and necessitate liver transplantation if left untreated or undertreated.
  • The case study highlights the importance of early diagnostic workup and prompt multidisciplinary management of SCIC.
  • A 24-year-old male patient was diagnosed with SCIC after presenting with jaundice, encephalopathy, and epistaxis.
  • The patient underwent liver transplantation due to ongoing complications and recurrent admissions.
  • Liver biopsy revealed sinusoidal red cell sickling, fibrosis, and ductopenia, consistent with findings of SCIC.
  • The patient experienced complications including perihepatic hematoma and stroke.

Statistics:

  • The patient was 24 years old.
  • The patient experienced hyperbilirubinemia, coagulopathy, portal hypertension, and acute kidney injury (AKI).
  • SCIC is a rare complication of SCD, but it can have severe outcomes if left untreated or undertreated.
  • The patient underwent liver transplantation after experiencing recurrent admissions and symptomatic coagulopathy.
  • The patient's presentation was concerning for SCIC due to the combination of symptoms including jaundice, encephalopathy, and epistaxis.

Sources:

  • NewsRx. Studies from Department of Pediatrics in the Area of Intrahepatic Cholestasis Described (Epistaxis: A Rare Presentation of Sickle Cell Intrahepatic Cholestasis). Gastroenterology Week. 2025; p 2347.
  • Epistaxis: A Rare Presentation of Sickle Cell Intrahepatic Cholestasis. Case Reports in Hematology, 2025. DOI: 10.1155/crh/2660044.

Read more